VTR
Ventas, Inc. NYSE$87.79
Pre-mkt
$87.79
+0.01%
Mkt Cap $42.7B
52w Low $61.76
97.3% of range
52w High $88.50
50d MA $84.89
200d MA $76.40
P/E (TTM)
160.0x
EV/EBITDA
21.3x
P/B
3.2x
Debt/Equity
1.1x
ROE
2.4%
P/FCF
26.7x
RSI (14)
—
ATR (14)
—
Beta
0.77
50d MA
$84.89
200d MA
$76.40
Avg Volume
3.5M
About
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success i…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | AMC | 0.12 | 0.11 | -10.5% | 84.70 | +0.0% | +3.4% | +3.2% | +3.7% | +3.9% | — | — | — |
| Feb 5, 2026 | AMC | 0.10 | 0.15 | +49.0% | 79.84 | +1.2% | +3.4% | +3.6% | +5.1% | +7.3% | +6.7% | +8.0% | — |
| Oct 29, 2025 | AMC | 0.87 | 0.88 | +1.1% | 69.78 | +1.0% | +6.6% | +5.7% | +6.2% | +7.4% | +7.5% | +15.5% | — |
| Jul 30, 2025 | AMC | 0.85 | 0.87 | +2.4% | 66.48 | -1.0% | +1.1% | +1.5% | +2.7% | +3.4% | +3.0% | +2.4% | — |
| Apr 30, 2025 | AMC | 0.82 | 0.84 | +2.4% | 70.08 | -2.0% | -6.5% | -5.0% | -4.9% | -6.1% | -5.7% | -8.3% | — |
| Feb 12, 2025 | AMC | -0.02 | 0.81 | +4150.0% | 59.94 | +0.2% | +8.3% | +11.0% | +11.4% | +11.7% | +11.5% | +11.6% | — |
| Oct 30, 2024 | AMC | 0.80 | 0.80 | +0.0% | 66.48 | -2.7% | -1.5% | -3.4% | -3.2% | -3.0% | -4.9% | -3.6% | — |
| Aug 1, 2024 | AMC | 0.79 | 0.80 | +1.3% | 55.30 | +0.3% | +2.0% | +0.7% | +3.4% | +4.5% | +6.7% | +12.9% | — |
| May 1, 2024 | AMC | 0.74 | 0.78 | +5.4% | 43.81 | +5.0% | +5.5% | +6.8% | +7.4% | +7.6% | +8.3% | +14.7% | — |
| Feb 14, 2024 | AMC | 0.76 | 0.76 | +0.0% | 45.61 | -5.1% | -3.1% | -4.1% | -5.6% | -3.4% | -3.3% | -6.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Evercore ISI | Maintains | Outperform → Outperform | — | $87.58 | $87.57 | -0.0% | -0.2% | +0.3% | +0.5% | — | — |
| Mar 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $82.70 | $82.47 | -0.3% | -0.0% | -1.0% | -1.3% | -1.1% | -0.8% |
| Mar 20 | JP Morgan | Maintains | Overweight → Overweight | — | $85.55 | $85.55 | +0.0% | -3.6% | -4.3% | -3.9% | -3.3% | -3.4% |
| Mar 4 | Mizuho | Maintains | Outperform → Outperform | — | $86.50 | $86.57 | +0.1% | +0.3% | -1.8% | -1.9% | -0.3% | -0.5% |
| Mar 2 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $86.16 | $86.57 | +0.5% | +0.6% | +0.4% | +0.7% | -1.4% | -1.5% |
| Feb 11 | Citigroup | Maintains | Buy → Buy | — | $83.90 | $84.15 | +0.3% | +2.1% | +1.5% | +1.6% | +3.6% | +2.2% |
| Feb 10 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $82.75 | $82.82 | +0.1% | +1.4% | +3.6% | +3.0% | +3.0% | +5.0% |
| Feb 10 | RBC Capital | Maintains | Outperform → Outperform | — | $82.75 | $82.82 | +0.1% | +1.4% | +3.6% | +3.0% | +3.0% | +5.0% |
| Feb 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $82.55 | $83.41 | +1.0% | +0.2% | +1.6% | +3.8% | +3.2% | +3.3% |
| Dec 4 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $80.00 | $79.72 | -0.3% | +0.6% | +0.8% | +1.2% | +0.0% | -2.8% |
Recent Filings
8-K
Ventas, Inc. -- 8-K Filing
Ventas reported first-quarter 2026 results, with the company providing operational and financial performance updates to investors during the earnings announcement period.
Apr 27
8-K · 5.02
!!! Very High
Ventas, Inc. -- 8-K 5.02: Executive Change
Ventas Inc. experienced executive departure as Gregory R. Liebbe resigned from his Senior Vice President position, potentially signaling organizational restructuring or strategic shifts at the healthcare real estate investment trust.
Feb 20
8-K · 8.01
!! High
Ventas, Inc. -- 8-K 8.01: Material Event / Announcement
Ventas, Inc. arranged a forward equity offering with twelve major financial institutions as forward purchasers, allowing the REIT to raise capital while deferring share issuance and dilution.
Feb 9
8-K
Ventas, Inc. -- 8-K Filing
Ventas increased its dividend while reporting full-year 2025 results and providing 2026 guidance, signaling management confidence in the healthcare real estate REIT's operational performance and cash generation.
Feb 5
Data updated apr 27, 2026 8:26am
· Source: massive.com